Programmed death ligand-1 (PD-L1) as a predictive marker for immunotherapy in solid tumours: a guide to immunohistochemistry implementation and interpretation

Elizabeth C. Paver, Wendy A. Cooper, Andrew J. Colebatch, Peter M. Ferguson, Sean K. Hill, Trina Lum, Joo‐Shik Shin, Sandra A. O’Toole, Lyndal Anderson, Richard A. Scolyer, Ruta Gupta